# Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

> **NCT06058520** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 16 (estimated)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Fecal Microbiota - lyophilized
- **DRUG:** Placebo drug

## Key facts

- **NCT ID:** NCT06058520
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06058520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06058520, "Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06058520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*